0001062993-23-022023.txt : 20231206
0001062993-23-022023.hdr.sgml : 20231206
20231206160722
ACCESSION NUMBER: 0001062993-23-022023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231204
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pfeiffenberger Brent
CENTRAL INDEX KEY: 0002001162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40498
FILM NUMBER: 231469677
MAIL ADDRESS:
STREET 1: C/O CENTURY THERAPEUTICS, INC.
STREET 2: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Century Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850119
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842040295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 215-981-4000
MAIL ADDRESS:
STREET 1: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-04
0001850119
Century Therapeutics, Inc.
IPSC
0002001162
Pfeiffenberger Brent
C/O CENTURY THERAPEUTICS, INC.
25 N 38TH STREET, 11TH FLOOR
PHILADELPHIA
PA
19104
1
1
0
0
President and CEO
0
Common Stock
2023-12-04
4
A
0
1173775
0
A
1173775
D
Common Stock
2023-12-04
4
A
0
279504
0
A
1453279
D
Stock Option (right to buy)
1.61
2023-12-04
4
A
0
573691
0
A
2033-12-04
Common Stock
573691
573691
D
Reflects a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs underlying this grant shall vest 25% on December 4, 2024, with the remaining 75% vesting in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, subject to the Reporting Person's continued service through each applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
Reflects a grant of RSUs. The RSUs underlying this grant shall vest in full on December 4, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
The option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ Michael Diem, Attorney-in-Fact
2023-12-06